Self-Assembling Nanoparticles Claimed to Represent Personalized Medicine "Milestone"

Current approaches to the targeted delivery of therapeutics such as gene-silencing nucleic acids have to date tended to focus on a single-target cell receptor, but truly personalized treatments for many diseases, such as cancer, will require the ability to target potentially multiple cell types and their receptors, which will vary between individuals. This has been technologically challenging, not least from a design and production perspective.Researchers at Tel Aviv University (TAU) have now de